About the Linvoseltamab Clinical Development Program Linvoseltamab is an investigational BCMAxCD3 bispecific antibody designed to bridge B-cell maturation antigen (BCMA) on MM cells with ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...